Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 2Other 2Gastrointestinal 2Thoracic 1Plasma cell 1

Conditions

Obesity 92Overweight 35Neoplasms 32Breast Neoplasms 23Sexual Dysfunction, Physiological 19Dyspnea 15Weight Loss 12Motor Activity 12Endometrial Neoplasms 11Polycystic Ovary Syndrome 10Mucositis 8Diabetes Mellitus, Type 2 8Diabetes Mellitus 8Obesity-Related Malignant Neoplasm 7Hypertension 7Depression 7Anxiety Disorders 7Pediatric Obesity 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Sexual Dysfunctions, Psychological 5Obesity, Morbid 5Lung Neoplasms 5Leukemia 5Endometrial Hyperplasia 5Disease 5Constipation 5Sedentary Behavior 4Pulmonary Disease, Chronic Obstructive 4Prostatic Neoplasms 4

Interventions

naldemedine 1isatuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nausea × Other × 1 year × Clear all
NCT07038551 2026-06-03

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Completed
120 enrolled
Other

Constipation, Nausea, Vomiting

NCT03499808 2025-09-09

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

SWOG Cancer Research Network

Phase 2 Completed
43 enrolled 23 charts
GastrointestinalOtherPlasma cell

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

Data powered by HemOnc (CC BY 4.0) Colophon âš¡